---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-008048"
form_type: "8-K"
ticker: "HRGN"
cik: "0001563665"
company_name: "Harvard Apparatus Regenerative Technology, Inc."
filed_at: "2022-01-27T23:59:59+00:00"
generated_at: "2026-06-27T14:57:33.318562+00:00"
event_type: "litigation"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Biostage wins court order requiring insurer to pay legal defense; to host investor webinar Jan 27

## Summary
- Court ordered Medmarc to continue paying Biostage's legal defense in a wrongful death suit over a tracheal implant, finding Medmarc breached its duty and awarding attorneys' fees.
- Biostage discontinued tracheal implant development and now focuses on esophageal implant, which has FDA approval for a clinical trial.
- Interim CEO David Green will host webinars on Jan 27 to discuss the clinical trial, capital raising, and NASDAQ uplisting.
- A second webinar is scheduled for Jan 27 at 8pm ET / Jan 28 9am Beijing time for investor Q&A.

## SEC filing metadata
- accession: 0001104659-22-008048
- form_type: 8-K
- ticker: HRGN
- cik: 0001563665
- company_name: Harvard Apparatus Regenerative Technology, Inc.
- filed_at: 2022-01-27T23:59:59+00:00
- event_type: litigation
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1563665/000110465922008048/0001104659-22-008048-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1563665/000110465922008048/tm224636d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-008048
- JSON: https://secwatch.observer/filing/0001104659-22-008048.json
- Plain text: https://secwatch.observer/filing/0001104659-22-008048.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.